Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.


Autoria(s): Tejpar S.; Saridaki Z.; Delorenzi M.; Bosman F.; Roth A.D.
Data(s)

2011

Identificador

http://serval.unil.ch/?id=serval:BIB_FE1736842866

isbn:1460-2105 (Electronic)

pmid:21597023

doi:10.1093/jnci/djr170

isiid:000291490900002

Idioma(s)

en

Fonte

Journal of the National Cancer Institute, vol. 103, no. 11, pp. 841-844

Palavras-Chave #Antimetabolites, Antineoplastic/administration & dosage; Antimetabolites, Antineoplastic/adverse effects; Chemotherapy, Adjuvant; Colorectal Neoplasms/drug therapy; Colorectal Neoplasms/genetics; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics; CpG Islands/genetics; DNA Methylation; DNA Mismatch Repair/genetics; Disease-Free Survival; Fluorouracil/administration & dosage; Fluorouracil/adverse effects; Gene Silencing; Germ-Line Mutation; Humans; Microsatellite Instability; Neoplasm Staging; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Treatment Failure
Tipo

info:eu-repo/semantics/article

article